Company News

Arxada Disinfectants Are Effective Against the Monkeypox Virus

EPA's List Q states eligible products for making off-label claims. Arxada's regulatory team can provide guidance.

Author Image

By: TOM BRANNA

Editor

In response to the Monkeypox virus outbreak, the EPA recently initiated emerging viral pathogen (EVP) status for Monkeypox virus. Arxada offers a variety of disinfectant solutions effective against the Monkeypox virus registered in accordance with the EVP program. Arxada's solutions include RTU, wipes, and concentrates for both consumers and professional markets. The EPA has published List Q, which states eligible products for making off-label claims against the Monkeypox virus. Arxada&#...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters